Cargando…
Genome-wide association study of leukotriene modifier response in asthma
Heterogeneous therapeutic responses to leukotriene modifiers (LTMs) are likely due to variation in patient genetics. Although prior candidate gene studies implicated multiple pharmacogenetic loci, to date, no genome-wide association study (GWAS) of LTM response was reported. In this study, DNA and p...
Autores principales: | Dahlin, A, Litonjua, A, Irvin, C G, Peters, S P, Lima, J J, Kubo, M, Tamari, M, Tantisira, K G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4668236/ https://www.ncbi.nlm.nih.gov/pubmed/26031901 http://dx.doi.org/10.1038/tpj.2015.34 |
Ejemplares similares
-
Genome-Wide Association Study Identifies Novel Pharmacogenomic Loci For Therapeutic Response to Montelukast in Asthma
por: Dahlin, Amber, et al.
Publicado: (2015) -
The phosphatidylinositide 3-kinase (PI3K) signaling pathway is a determinant of zileuton response in adults with asthma
por: Dahlin, Amber, et al.
Publicado: (2018) -
Role of Leukotrienes and Leukotriene Modifiers in Asthma
por: Montuschi, Paolo
Publicado: (2010) -
Genome-Wide Association Analysis in Asthma Subjects Identifies SPATS2L as a Novel Bronchodilator Response Gene
por: Himes, Blanca E., et al.
Publicado: (2012) -
Genome Wide Association Study to predict severe asthma exacerbations in children using random forests classifiers
por: Xu, Mousheng, et al.
Publicado: (2011)